Covaxin for kids: Bharat Biotech's partner requests approval for ages 2-18 in US
Shortpedia
Content Team
Image Credit: India Today
Ocugen, Bharat Biotech's US partner, has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18. "We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners - Ocugen," tweeted Dr Raches Ella, Bharat Biotech's clinical lead for Covid-19 vaccines.
